Pete Wegier

Dr. Pete Wegier

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Brain and Cognition
Verified
Journal Article
Closed access
RWRyan S. Williams
Ryan S. Williams
ABAnna Lena Biel
Anna Lena Biel
PWPete Wegier
Pete Wegier
LLLeann K. Lapp
Leann K. Lapp
BDBenjamin J. Dyson
Benjamin J. Dyson
JSJulia Spaniol
Julia Spaniol

16 August 2024 in Medicine
Verified
Journal Article
Open access
LGLiza Grosman-Rimon
Liza Grosman-Rimon
PWPete Wegier
Pete Wegier
The accelerated adoption of digital health technologies in the last decades has raised important ethical and safety concerns. Despite the potency and usefulness of digital health technologies, addressing safety, and ethical considerations needs to take greater prominence. This review paper focuses on ethical and safety facets, including health technology-related risks, users’ safety and well-being risks, security and privacy concerns, and risks to transparency and diminished accountability associated with the utilization of digital health technologies. In order to maximize the potential of health technology benefits, awareness of safety risks, and ethical concerns should be increased, and the use of appropriate strategies and measures should be considered.

1 July 2015 in Brain Research
Verified
Journal Article
Closed access
JSJulia Spaniol
Julia Spaniol
HBHolly J. Bowen
Holly J. Bowen
PWPete Wegier
Pete Wegier
CGCheryl Grady
Cheryl Grady

21 October 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
RBRavi Bhargava
Ravi Bhargava
BKBonnie Keating
Bonnie Keating
SISarina R. Isenberg
Sarina R. Isenberg
SSSaranjah Subramaniam
Saranjah Subramaniam
PWPete Wegier
Pete Wegier
MCMartin Robert Chasen
Martin Robert Chasen
The lack of timely symptom reporting remains a barrier to effective symptom management and comfort for patients with cancer-related palliative care needs. Poor symptom management at home can lead to unwanted outcomes, such as emergency department visits and death in hospital. We developed and evaluated RELIEF, a remote symptom self-reporting app for community patients with palliative care needs. A pilot feasibility study was conducted at a large, community hospital in Ontario, Canada. Patients self-reported their symptoms each morning using validated clinical symptom measures and RELIEF would alert for worsening or severe symptoms. RELIEF alerts were monitored by palliative care nurses who would then contact patients to determine if appropriate clinical intervention could be initiated to avoid unnecessary emergency department visits. A total of 20 patients were recruited to use RELIEF for two months. Patients completed 80% of daily self-report assessments; 133 alerts were trigged, half of which required clinical intervention. No patient visited the emergency department for symptom management during the study. Clinical staff estimated five emergency department visits were avoided because of RELIEF—saving an estimated cost of over CAD 60,000. RELIEF is a feasible and acceptable method for the remote monitoring of patients with palliative care needs through regular symptom self-reporting.

28 June 2019 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
PWPete Wegier
Pete Wegier
EKEllen Koo
Ellen Koo
SAShahin Ansari
Shahin Ansari
DKDaniel Kobewka
Daniel Kobewka
EOErin O'Connor
Erin O'Connor
James DownarJames Downar
James Downar
Objective The need for clinical staff to reliably identify patients with a shortened life expectancy is an obstacle to improving palliative and end-of-life care. We developed and evaluated the feasibility of an automated tool to identify patients with a high risk of death in the next year to prompt treating physicians to consider a palliative approach and reduce the identification burden faced by clinical staff. Methods Two-phase feasibility study conducted at two quaternary healthcare facilities in Toronto, Canada. We modified the Hospitalised-patient One-year Mortality Risk (HOMR) score, which identifies patients having an elevated 1-year mortality risk, to use only data available at the time of admission. An application prompted the admitting team when patients had an elevated mortality risk and suggested a palliative approach. The incidences of goals of care discussions and/or palliative care consultation were abstracted from medical records. Results Our model (C-statistic=0.89) was found to be similarly accurate to the original HOMR score and identified 15.8% and 12.2% of admitted patients at Sites 1 and 2, respectively. Of 400 patients included, the most common indications for admission included a frailty condition (219, 55%), chronic organ failure (91, 23%) and cancer (78, 20%). At Site 1 (integrated notification), patients with the notification were significantly more likely to have a discussion about goals of care and/or palliative care consultation (35% vs 20%, p = 0.016). At Site 2 (electronic mail), there was no significant difference (45% vs 53%, p = 0.322). Conclusions Our application is an accurate, feasible and timely identification tool for patients at elevated risk of death in the next year and may be effective for improving palliative and end-of-life care.

29 October 2018 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
JWJoshua Wales
Joshua Wales
SISarina R. Isenberg
Sarina R. Isenberg
PWPete Wegier
Pete Wegier
JSJennifer Shapiro
Jennifer Shapiro
VCVictor Cellarius
Victor Cellarius
NKNarges Khoshnood
Narges Khoshnood
Background: Medical Assistance in Dying (MAiD) was legalized in Canada in June 2016. There are no documented experiences of MAiD provision within a home palliative care program. The majority of palliative care physicians in Canada object to MAiD. As one of the largest home-based palliative care providers in Canada, the Temmy Latner Centre for Palliative Care (TLCPC) developed processes to implement MAiD provision within a home palliative care team with diverse attitudes toward MAiD. Objective: To demonstrate the feasibility of providing MAiD within a home palliative care setting and describe the population that received MAiD in the first year of legalization. Design: A retrospective chart review identified patients who received or were assessed for MAiD and had a known outcome between June 17, 2016 and June 30, 2017. Setting/Subjects: Patients receiving home-based palliative care. Measurements: Data extracted included age, gender, primary diagnosis, length of time receiving home-based palliative care, and final clinical outcome. Results: Of the 45 patients who were assessed for MAiD, 27 (60%) received MAiD and 18 (40%) did not. The mean age was 74 (range 20–95), 24 (53%) were male, and 33 (73%) had cancer as a primary diagnosis. These 27 patients represent 1.2% of our total patient population during this time period. Conclusions: MAiD was accessed by 1.2% of the patients within a home palliative care center in the first year of legalization. Patient demographics were consistent with those documented elsewhere. The TLCPC process accommodates the diverse viewpoints of clinicians and emphasizes continuity of palliative care provision.